Quantcast

Latest biotechnology Stories

2014-09-09 08:30:24

ORLANDO, Fla. and DUBLIN, Sept. 9, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced the results of its 2014 annual general meeting of shareholders. The shareholders of the Company have approved all the matters submitted to them at the Company's 2014 annual general meeting held at 10:00 a.m., Eastern...

2014-09-09 08:30:04

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Separation Systems Market in Biotechnology" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Macromolecules which include protein, RNA, DNA and nucleic acids undergo separation or are broken into smaller molecules, during production of commercially available biotechnological products. This separation requires various advanced systems like centrifugation, liquid...

2014-09-09 00:21:56

LONDON, Sept. 8, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Biotechnology Reagents Market 2014-2018https://www.reportbuyer.com/product/2355562/Global-Biotechnology-Reagents-Market-2014-2018.htmlAbout Biotechnology ReagentsBiotechnology reagents are chemical compounds or substances that are added to a system to detect and examine another substance to provide a test reading. Reagents are generally used in laboratories to prepare, collect, and...

2014-09-08 23:05:50

Okyanos Heart Institute Now Accepting Qualified Heart Disease Candidates for Adult Stem Cell Treatment in New State-of-the-Art Cath Lab Freeport, Grand Bahama (PRWEB) September 08, 2014 Adult stem cell therapy for heart disease has emerged as a new treatment alternative for those living with a poor quality of life as a result of severe coronary artery disease. Okyanos is slated to begin delivering this innovative new treatment in the next several weeks, and is now screening qualified...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...

2014-09-08 12:29:53

DALLAS, September 8, 2014 /PRNewswire/ -- ReportsnReports.com adds "Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) - Global Forecast to 2020" research report of 242 pages to its store. The global next generation sequencing market is dynamic and witnessing many...

2014-09-08 12:29:51

DUBLIN, Sept. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biochips Market (Microarrays/Lab on Chip)" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized...

2014-09-08 12:24:27

TNF-Alpha Inhibitors--Including Sales Leader Humira--Accounted for Over 90 Percent of the Psoriatic Arthritis Market, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 8, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for psoriatic arthritis (PsA) therapies will grow nearly 66 percent, increasing to $3.7 billion in 2023, owing to the continued uptake of premium-price biologics and novel therapies that are expected to launch during the 2013 to...

2014-09-08 08:31:19

SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, has exercised its option to acquire a novel antibody program from AnaptysBio. Upon payment of an option exercise fee to...

2014-09-08 08:28:59

REHOVOT, Israel, September 8, 2014 /PRNewswire/ -- CollPlant (TASE: CLPT), a developer and manufacturer of human collagen-based medical products has announced that Dr. Nadav Orr has been appointed Vice President of Research & Development, effective September 7, 2014. Dr. Nadav Orr brings over 15 years of experience in research and development, including 9 years in the development of Biosurgery products. Before joining Collplant, Nadav served as an Associate...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related